Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03671759 · ClinicalTrials.gov registry record · NA
Coffee and Real-time Atrial and Ventricular Ectopy
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT03671759 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 108 participants.
The verdict
NCT03671759, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
Atrial fibrillation (AF) and heart failure (HF) are morbid, costly, and incompletely understood diseases that have reached epidemic proportions worldwide. A dose-dependent relationship exists between premature atrial and ventricular contractions (PACs and PVCs) and development of AF and HF, respectively. Identifying and understanding the mechanisms of additional modifiable risk factors for ectopy has the potential to markedly reduce the healthcare burden of these diseases. In considering how to modify the prevalence of these ectopic beats, the investigators believe common exposures in daily life are prime candidates. Current guidelines suggest that caffeine may be an important trigger for frequent ectopy, although large population-based studies have not demonstrated an association between caffeine consumption and development of clinically significant arrhythmias. No study has employed an actual randomization intervention to assess the effects of caffeine on cardiac ectopy. Utilizing the Eureka platform, the investigators plan to utilize the N-of-1 strategy to rigorously investigate the real-time effect of caffeine intake on ectopy.
Interventions
- BEHAVIORAL Start: On Caffeine
- BEHAVIORAL Start: Off Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03671759
The ClinicalTrials.gov registry entry for NCT03671759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Start: On Caffeine is the first listed.
NCT03671759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03671759 about?
NCT03671759 is a clinical study titled "Coffee and Real-time Atrial and Ventricular Ectopy". Atrial fibrillation (AF) and heart failure (HF) are morbid, costly, and incompletely understood diseases that have reached epidemic proportions worldwide. A dose-dependent relationship exists between premature atrial and ventricular contractions (PACs and PVCs) and development of AF and HF, respecti...
What is the current status of trial NCT03671759?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2019-05-01. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT03671759?
The interventions under investigation include: Start: On Caffeine (BEHAVIORAL), Start: Off Caffeine (BEHAVIORAL).
Who is sponsoring clinical trial NCT03671759?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.